Watch for Labeling Changes About Amputations With Invokana

July 2017

You'll see a new boxed warning about an increased risk of amputations with the diabetes med, canagliflozin (Invokana, etc).

This is the latest in a growing list of "flozin" concerns...ketoacidosis, urinary tract infections, yeast infections, etc.

Amputations, mainly of the toe or mid-foot, are seen in about 6 in 1,000 patients taking canagliflozin per year...compared to about 3 in 1,000 patients per year on other diabetes meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Adherence Take Steps to Reduce the Number of Return-to-Stock Rxs
Inhalers AirDuo Is NOT a Generic for Advair
Pediatrics Ask for a Child's Weight at Drop-Off...Even for Refills
Transdermal Patches Help Avoid Common Errors With Transdermal Patches
Corticosteroids Expect to See Fewer Rxs for Short Courses of Oral Steroids
Parkinson's Disease Think of Xadago as Similar to Selegiline or Rasagiline for Parkinson's Disease
Diabetes Watch for Labeling Changes About Amputations With Invokana
Osteoporosis Stay Alert for Mix-Ups With Meds for Treating Osteoporosis
UTIs Be Prepared to Handle Unusual Antibiotic Rxs for Recurrent UTIs
Heart Failure Prevent Mishaps With Entresto or Corlanor in Heart Failure Patients
Musculoskeletal Look for Meds Linked to Nighttime Leg Cramps

Watch for Labeling Changes About Amputations With Invokana

Practical advice for a better career, with unlimited access to CE

Table of Contents